Lorazepam Concentrate
Product Images NDC 65162-687

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lorazepam (NDC 65162-687). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Lorazepam Oral Concentrate Usp 1)

Chemical structure of lorazepam showing its chlorinated benzodiazepine core with characteristic rings and functional groups.*

FDA Label Image

2 mg/ml (Lorazepam Oral Concentrate Usp 2)

Lorazepam Oral Concentrate, USP 2 mg/mL is a human prescription drug concentrate in a 30 mL bottle, distributed by Amneal Pharmaceuticals LLC. The label includes dosage instructions, storage requirements to refrigerate at 2° to 8°C, a graduated dropper volume scale, and a note to discard the bottle 90 days after opening.*

FDA Label Image

2 mg/ml (Lorazepam Oral Concentrate Usp 3)

Lorazepam Oral Concentrate, USP 2 mg/mL concentrate in a 30 mL oral solution bottle label by Amneal Pharmaceuticals LLC. The label includes dosage information, storage instructions (refrigerate at 2 to 8°C), dropper calibration for dose measurement, and safety notes such as discarding the bottle after 90 days and protecting from light. The label has the NDC 65162-687 and emphasizes use as a prescription drug.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.